|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Sapacitabine>> Market Analysis Reports |
Market Analysis Reports of Sapacitabine |
|
Sapacitabine (CAS 151823-14-2) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Sapacitabine Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Global Market Report of Sapacitabine (CAS 151823-14-2) December 2024 Cyclacel Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... development priorities are focused on sapacitabine in the following indications: ... for xerostomia. Sapacitabine The companys main candidate, sapacitabine, is an orally ... with a structure similar to a nucleoside. Sapacitabine acts through a dual mechanism ... CAS 151823-14-2 Sapacitabine Chemical Report & Database ... Consumption Report & Database definitions: Name: Sapacitabine: Sapacitabine; CS-682; N-[1-[(2R,3S,4S,5R)-3-Cyano-4-hydroxy-5-(hydroxymethyl)oxolan ... APPLICATIONS: Chemical or Reaction Intermediate The Sapacitabine Report & Database gives Market Consumption ... Global Leukemia Treatment Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023 ... ) Market Segment by Type, covers Gleevec Sapacitabine GA101 Vasaroxine Tosedosat Revlimid Bosutinib ... Global Leukemia Treatment Drugs Market Report 2020 ... USD—— Product Type Segmentation Gleevec Sapacitabine GA101 Vasaroxine Tosedosat Industry Segmentation ... Global Leukemia Treatment Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029 ... markets. Market segment by Type Gleevec Sapacitabine GA101 Vasaroxine Tosedosat Revlimid Bosutinib ... Global Leukemia Treatment Drugs Market Growth (Status and Outlook) 2025-2031 ... and countries. Segmentation by Type: Gleevec Sapacitabine GA101 Vasaroxine Tosedosat Revlimid Bosutinib ... Cyclin Dependent Like Kinase 5 (Serine/Threonine Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or Cell Division Protein Kinase 5 or CDK5 or EC 2.7.11.1) - Pipeline Review, H2 2017 Cyclin Dependent Like Kinase 5 (Serine/Threonine Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or Cell Division Protein Kinase 5 or CDK5 or EC 2.7.11.1) - Pipeline Review, H2 2017 SUMMARY According to the recently published report ' ... Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Pipeline Review, H1 2018 Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Pipeline Review, H1 2018 SUMMARY Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) pipeline ... Acute Myeloid Leukemia - Pipeline Review, 2019 ... Guadecitabine Volasertib Daunorubicin Crenolanib AB8939 Sapacitabine Liposomal Annamycin MGD006 SEL 120 ... Leukemia Treatment Drugs Market, Global Outlook and Forecast 2022-2028 ... Segment Percentages, by Type, 2021 (%) Gleevec Sapacitabine GA101 Vasaroxine Tosedosat Revlimid Bosutinib ... Therapeutic Class Overview: Treating Refractory Hematological Malignancies Targeting unmet needs in the treatment of cancer/ hematological malignancies through innovative drug development strategies have witnessed favorable outcomes. Over the past decade, Proteasome inhibitor, Velcade (bortezomib) and the immunomodulatory drugs ... Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell Division Protein Kinase 9 or Serine/Threonine Protein Kinase PITALR or CDK9 or EC 2.7.11.22 or EC 2.7.11.23) - Pipeline Review, H1 2018 Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell Division Protein Kinase 9 or Serine/Threonine Protein Kinase PITALR or CDK9 or EC 2.7.11.22 or EC 2.7.11.23) - ... Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Pipeline Review, H2 2018 Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Pipeline Review, H2 2018 SUMMARY Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) pipeline ... Cyclin Dependent Kinase 7 (39 kDa Protein Kinase or CDK Activating Kinase 1 or Cell Division Protein Kinase 7 or TFIIH Basal Transcription Factor Complex Kinase Subunit or Serine/Threonine Protein Kinase 1 or CDK7 or EC 2.7.11.22 or EC 2.7.11.23) - Pipeline Review, H2 2018 Cyclin Dependent Kinase 7 (39 kDa Protein Kinase or CDK Activating Kinase 1 or Cell Division Protein Kinase 7 or TFIIH Basal Transcription Factor Complex Kinase Subunit or Serine/Threonine Protein Kinase 1 or CDK7 or EC 2.7.11.22 or EC 2.7.11.23) - ... Cyclin Dependent Kinase 7 (39 kDa Protein Kinase or CDK Activating Kinase 1 or Cell Division Protein Kinase 7 or TFIIH Basal Transcription Factor Complex Kinase Subunit or Serine/Threonine Protein Kinase 1 or CDK7 or EC 2.7.11.22 or EC 2.7.11.23) - Pipeline Review, H1 2018 Cyclin Dependent Kinase 7 (39 kDa Protein Kinase or CDK Activating Kinase 1 or Cell Division Protein Kinase 7 or TFIIH Basal Transcription Factor Complex Kinase Subunit or Serine/Threonine Protein Kinase 1 or CDK7 or EC 2.7.11.22 or EC 2.7.11.23) - ... Cyclin Dependent Kinase 2 - Pipeline Review, H2 2020 Cyclin Dependent Kinase 2 - Pipeline Review, H2 2020 SUMMARY Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Cyclin-dependent kinase 2 is an enzyme encoded by the CDK2 gene. CDK2 is the catalytic ... Cyclin Dependent Kinase 7 - Pipeline Review, H2 2019 Cyclin Dependent Kinase 7 - Pipeline Review, H2 2019 SUMMARY Cyclin Dependent Kinase 7 (39 kDa Protein Kinase or CDK Activating Kinase 1 or Cell Division Protein Kinase 7 or TFIIH Basal Transcription Factor Complex Kinase Subunit or Serine/Threonine ... |